Monday, April 21, 2025 11:59:42 AM
What lies have I told about RDGL? Are you denying that:
To date MK has only revealed one anecdote about one of the initial five patients, and in that case the treated tumor survived 30 days post treatment?
His update since then regarding 5 additional phase 1 patients revealed nothing more beyond some glittering generalities?
MK made absurd claim that the 5 initial trial patients in India with metastatic cancer are “doing well”?
Dr. Fisher so fubared the rabbit tests in 2021 they had to be repeated at JHU in 2023?
After years of pre-sub discussions, MK so fubared the June 2024 IDE application, he withdrew the application?
MK said in July (after withdrawing his fubared IDE application) that he was confident the application would resubmitted within 45 days, then this year he said 2nd quarter this year, now he's saying in 3rd quarter?
MK failed to get Radiogel to market before all the patents he licensed from Battelle expired and the tech became public domain?
MK lied in May of 2021 about submitting IDE application within 90-120 days (by Sept 21, 2021)?
MK failed to document and safely store gel formula/procedure, so the know-how was lost in 2021. As a result RDGL couldn't supply IsoPet for most of 2021 and had to start over with FDA?
MK lied on multiple occasions he had enough cash on hand to get through IDE approval, only to have each lie followed by an offering?
MK dishonestly makes post release edits to updates without indicating they're edited or the edit date?
MK lied in 2023 that the JHU rabbit testing had concluded when it hadn't?
MK took most of a year to write up the JHU rabbit results after saying it would take six weeks?
MK has repeatedly made unsubstantiated product attribute and comparative safety claims, with no evidence whatsoever, putting everything he says and submits to FDA under a magnifying glass?
The tech is public domain now. There is no evidence MK's patented "improvements" yield any performance advantages over what RDGL did before 2022.
To date MK has only revealed one anecdote about one of the initial five patients, and in that case the treated tumor survived 30 days post treatment?
His update since then regarding 5 additional phase 1 patients revealed nothing more beyond some glittering generalities?
MK made absurd claim that the 5 initial trial patients in India with metastatic cancer are “doing well”?
Dr. Fisher so fubared the rabbit tests in 2021 they had to be repeated at JHU in 2023?
After years of pre-sub discussions, MK so fubared the June 2024 IDE application, he withdrew the application?
MK said in July (after withdrawing his fubared IDE application) that he was confident the application would resubmitted within 45 days, then this year he said 2nd quarter this year, now he's saying in 3rd quarter?
MK failed to get Radiogel to market before all the patents he licensed from Battelle expired and the tech became public domain?
MK lied in May of 2021 about submitting IDE application within 90-120 days (by Sept 21, 2021)?
MK failed to document and safely store gel formula/procedure, so the know-how was lost in 2021. As a result RDGL couldn't supply IsoPet for most of 2021 and had to start over with FDA?
MK lied on multiple occasions he had enough cash on hand to get through IDE approval, only to have each lie followed by an offering?
MK dishonestly makes post release edits to updates without indicating they're edited or the edit date?
MK lied in 2023 that the JHU rabbit testing had concluded when it hadn't?
MK took most of a year to write up the JHU rabbit results after saying it would take six weeks?
MK has repeatedly made unsubstantiated product attribute and comparative safety claims, with no evidence whatsoever, putting everything he says and submits to FDA under a magnifying glass?
The tech is public domain now. There is no evidence MK's patented "improvements" yield any performance advantages over what RDGL did before 2022.
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
